[Proliferation evaluation by measuring Ki67 in breast neoplasms].
作者信息
Vincent-Salomon Anne
机构信息
Inserm U830, département de pathologie, institut Curie, 26, rue d'Ulm, 75248 Paris cedex 05, France.
出版信息
Ann Pathol. 2011 Nov;31(5 Suppl):S57-9. doi: 10.1016/j.annpat.2011.08.022. Epub 2011 Sep 28.
PMID:22054462
Abstract
摘要
相似文献
1
[Proliferation evaluation by measuring Ki67 in breast neoplasms].
Ann Pathol. 2011 Nov;31(5 Suppl):S57-9. doi: 10.1016/j.annpat.2011.08.022. Epub 2011 Sep 28.
2
[Ki67, nucleolus and cancer].
Ann Pathol. 2011 Nov;31(5 Suppl):S46-8. doi: 10.1016/j.annpat.2011.08.026. Epub 2011 Sep 25.
3
[When to use Ki67].
Ann Pathol. 2011 Nov;31(5 Suppl):S52-4. doi: 10.1016/j.annpat.2011.08.021. Epub 2011 Sep 25.
4
PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinico-pathologic aspects.
Pathologica. 1993 Jan-Feb;85(1095):47-55.
5
Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index.
Histopathology. 2006 May;48(6):674-82. doi: 10.1111/j.1365-2559.2006.02402.x.
6
Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
Anticancer Res. 1995 Nov-Dec;15(6B):2717-22.
7
[Cell cycle regulators as prognostic factors of breast cancers].
Nihon Rinsho. 2000 Apr;58 Suppl:448-53.
8
[How to evaluate Ki67].
Ann Pathol. 2011 Nov;31(5 Suppl):S49-51. doi: 10.1016/j.annpat.2011.08.025. Epub 2011 Sep 28.
9
[Ki67 and neuroendocrine tumors].
Ann Pathol. 2011 Nov;31(5 Suppl):S55-6. doi: 10.1016/j.annpat.2011.08.027. Epub 2011 Oct 1.
10
Correlation between Ki67 and breast cancer prognosis.
Oncology. 2013;84(4):219-25. doi: 10.1159/000346475. Epub 2013 Jan 24.
Zotero 插件